Neurochem (NRMX) Continues to race for the bottom. On Monday, the company said its Alzheimer’s disease treatment candidate, Alzhemed, failed a late-stage trial. The NRMX says it has 15 to 18 months of cash left. Maybe. Drops to $2.16 from 52-week high of $26.51.
Conexant (CNXT) Israel’s Orckit Communications wins arbitration and CNXT has to pay $12 million. Does not seem like a lot but stock drops to $1.06 from 52-week high of $2.36.
Tenet Healthcare (THC) Credit Suisse analyst launched coverage on the company with an "Underperform" rating. Down to $3.29 from 52-week high of $8.69.
Lennar (LEN) Home builder. Enough said. Down to $27.26 from 52-week high of $56.54.
Centex (CTX) Home builder. Ditto. Down to $28.13 from 52-week high of $58.42.
Horton (DHI) Another home builder. Drops to $14.40 from 52-week high of $31.13.
Leapfrog (LF) Bad quarter recently and toy companies are not all the rage right now. Down to $6.91 from 52-week high of $11.56.
Douglas A. McIntyre
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
